New Study Links Arthritic Pain to High Levels of Depression and Anxiety: Could Rose-hip be the Answer? World Mental Health Day is (Saturday 10th October 2020), is just around the corner, an event committed to raising awareness of mental health issues and mobilising support efforts. The importance of mental health is increasingly in the spotlight, however often overlooked is the hidden impact of chronic health conditions such as arthritis on an often invisible, but considerable, proportion of society.
A new study, published last month in the European Journal of Pain, highlights a strong link between the persistent pain experienced by arthritis patients and increased suffering from anxiety and depression1.
10 million people in the UK live with arthritis, a figure that is predicted to rise to 17 million by 20302. Sufferers experience debilitating symptoms including chronic joint pain, inflammation, stiffness, reduced mobility and fatigue, causing lifestyle changes that impact all areas of wellbeing.
According to a recent Joint Health of the Nation Report, one in five adults with arthritis have been found to experience depression and anxiety2, largely as a result of the increased pain of arthritic joints. Studies have shown that pain is the largest impacting factor to health-related quality of life within the UK, followed by depression and osteoarthritis3 – a condition of which one third of the population aged over 45 have sought treatment4.
A survey by GOPO® Joint Health5 found that joint pain caused:
- 62% to struggle with walking
- 25% to have their social life and ability to work impacted
- Nearly 50% to have difficulty getting in and out of the car
As a result, many were found to suffer from loneliness and isolation, causing a profound impact on mental health and contributing to 20% suffering from depression and anxiety2. These results highlight the need for a broader approach to the care of arthritis patients, and a sustainable long-term solution to pain relief.
According to the mental health charity Mind, signs that someone is suffering from depression include; lack of interest in activities, changes in sleep patterns, lack of energy, inability to concentrate, weight loss or gain and suicidal thoughts. Meanwhile anxiety is characterised by feelings of tension, panic and worry as well as increased blood pressure.
According to Dr Alastair Dickson, GP and Health Economist with an interest in rheumatology and arthritis;
“Osteoarthritis is common with patients typically presenting complaining of joint pain. This pain affects patients’ quality of life. Studies show that persistent pain can lead to depression as well as restricting activities. Accessing advice on ways to manage and treat your osteoarthritis is best done early, with chemists, first contact physiotherapists as well as GPs able to give you advice on self-management and treatment. Self-management options might include keeping mobile through daily exercise, losing weight, over the counter medications and supplements.”
Scientifically backed food supplements offer hope for patients seeking pain relief without dependence on painkillers, which are shown to have potentially harmful side effects if taken long-term. Experts believe that a key ingredient, the natural anti-inflammatory compound GOPO®, derived from rose-hips could help to reduce pain and tenderness in joints, without the risk of side effects.
Numerous extensive scientific studies have shown that the galactolipid GOPO® produces significant and consistent pain relief and improved joint function6-10, enabling reduced consumption of painkillers by as much as 40%7 over a three-month period. In one study, 8 out of 10 patients reported a significant reduction in pain after just 3 weeks of GOPO®7.
The success of GOPO® Joint Health in relieving joint pain and increasing mobility enables those affected by joint health conditions to maintain a fulfilling and active life, free from the burden of their symptoms.
Here are our top 5 tips for caring for your mental wellbeing whilst dealing with Arthritis;
Top 5 Tips for Good Mental Health While Managing Arthritis
- Take regular, gentle exercise like walking, swimming and yoga to keep your joints supple while also increasing endorphin production – the feel-good hormone!
- Take a natural supplement, such as GOPO® Joint Health, to help maintain your joint health and improve mood and wellbeing.
- Eat plenty of fresh fruit and vegetables, whole grains, nuts and seeds and at least two portions of oily fish per week – fresh foods and nuts contain antioxidant nutrients that can help reduce inflammation and protect against cell damage and the fish oils can help prevent and manage arthritic conditions.
- Get good sleep. Good quality sleep is suggested to reduce inflammation in the body and thus pain. Create a strict bedtime routine, avoiding electronic devices before bed as well as caffeine and alcohol.
- Do something for yourself! From your favourite hobby, to spending time with friends or even just relaxing with your favourite book can all help alleviate stress and improve mental health.
GOPO® Joint Health
GOPO® has been evaluated in numerous rigorously-conducted, placebo-controlled, clinical trials involving hundreds of patients with difficult-to-treat chronic joint conditions, including osteoarthritis and rheumatoid arthritis6-10. Efficacy results have been consistently positive and evidence supporting the benefits of GOPO® has been presented around the world at numerous clinical meetings and many studies have been published in peer-reviewed journals.
HOW THE GALACTOLIPID, GOPO®, WORKS
Laboratory studies into GOPO® have demonstrated that it can switch off certain genes responsible for producing proteins and enzymes that have been implicated in inflammatory joint destruction and switch on genes that help to produce collagen and cartilage9, which are essential components of a healthy joint. This suggests that when taken long term, the galactolipid GOPO® may protect cartilage cells and help to rebuild joint tissues9.
High levels of the galactolipid GOPO® are found only in GOPO® Joint Health
GOPO® Joint Health is also rich in vitamin C which is essential for normal collagen formation, needed by the body for healthy bones and cartilage.
GOPO® Joint Health is available from Boots, Amazon, supermarkets and independent chemists nationwide and is priced at £19.52 for 120 capsules and £29.60 for 200 capsules.
Visit www.gopo.co.uk for further information.
1. Vergne‐Salle, P, Pouplin, S, Trouvin, AP, et al. The burden of pain in rheumatoid arthritis: Impact of disease activity and psychological factors. Eur J Pain. 2020; 00: 1– 11. https://doi.org/10.1002/ejp.1651
2. Joint Health of the Nation Report, 2019
3. Wu, Mengjun et al. “Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample.” The European journal of health economics : HEPAC : health economics in prevention and care vol. 16,2 (2015): 141-51. doi:10.1007/s10198-013-0559-z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339694/
5. GOPO® Joint Health Survey, Censuswide, 2017
6. Willich SN, Rossnagel K, Roll S, et al. Rose hip herbal remedy in patients with rheumatoid arthritis – a randomised controlled trial. Phytomedicine. 2010;17(2):87-93. doi:10.1016/j.phymed.2009.09.003
7. Winther, K et al. “A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial.” Scandinavian journal of rheumatology vol. 34,4 (2005): 302-8. doi:10.1080/03009740510018624
8. Christensen R et al. Does the hip powder of Rose canina (rose-hip) reduce pain in osteoarthritis patients? – a meta-analysis of randomised controlled trials, Osteoarthritis Cartilage (2008)
9. Schwager J, Richard N, Wolfram S. Anti-inflammatory and chondro-protective effects of rose-hip powder and its constituent galactolipids GOPO. Poster presentation at the World Congress of Osteoarthritis (OARSI) 2008
10. Scaife R. The effect of GOPO supplementation on passive joint forces and subjective assessment of pain in a non-arthritic population. Poster presentation at the International Sports Science and Sports Medicine Conference 2013, Newcastle, August 21-23